Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape
Pharmacy Times
JUNE 12, 2025
Because biologics and biosimilar products are large and complex proteins, there is a higher risk of a patient’s body identifying them as an “outside source” and mounting an immune response to them. Our bodies don't like foreign sources. They like the things that it creates itself.
Let's personalize your content